Atara Biotherapeutics, Inc. announced the closing of the expanded global partnership with Pierre Fabre Laboratories for tabelecleucel (tab-cel or Ebvallo)
South Korea�s Ministry of Food and Drug Safety (MFDS) has upheld its conditional approval of Olita Tab (olmutinib) (also known...
Atara Biotherapeutics announced that the Marketing Authorization Application (MAA) for tab-cel (tabelecleucel) has been fully validated by the European Medicines Agency (EMA).